State of the Art in Idiopathic Pulmonary Fibrosis

This reprint is a compilation of ten publications, including original-research and review articles, and the accompanying editorial within the scope of a Special Issue entitled: "State of the Art in Idiopathic Pulmonary Fibrosis" published in Cells.

Spremljeno u:
Bibliografski detalji
Format: Online
Jezik:engleski
Izdano: MDPI - Multidisciplinary Digital Publishing Institute 2023
Teme:
Online pristup:ONIX_20230202_9783036563855_77
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
_version_ 1869518925436289024
collection Directory of Open Access Books
description This reprint is a compilation of ten publications, including original-research and review articles, and the accompanying editorial within the scope of a Special Issue entitled: "State of the Art in Idiopathic Pulmonary Fibrosis" published in Cells.
format Online
id doab-20.500.12854ir-96676
institution Directory of Open Access Books
language eng
publishDate 2023
publishDateRange 2023
publishDateSort 2023
publisher MDPI - Multidisciplinary Digital Publishing Institute
publisherStr MDPI - Multidisciplinary Digital Publishing Institute
record_format ojs
spelling doab-20.500.12854ir-966762024-03-30T23:22:24Z State of the Art in Idiopathic Pulmonary Fibrosis Wygrecka, Malgorzata El Agha, Elie interstitial fibrosis lung alveolar fibroelastosis idiopathic pulmonary fibrosis pirfenidone nintedanib discontinuation body mass index adverse event antifibrotic treatment IPF alveolar epithelial cells intermediate epithelial cells transitional states LysoTracker flow cytometry lung transcriptomic profile CK5 NGFR CD24 epidermal growth factor epidermal growth factor receptor ErbB-signaling pulmonary fibrosis lung fibrosis tyrosine kinase inhibitor TGF-α TGF-β amphiregulin neuregulin 1 basal cells bronchial epithelium airway epithelium MUC5B single cell RNA sequencing epithelial populations antibody folding immunophilin interstitial lung disease ER stress tacrolimus FK506-binding protein peptidyl-prolyl isomerase 3D cultures IPF modelling drug screening idiopathic pulmonary fibrosis (IPF) histone deacetylase (HDAC) histone acetylation non-histone protein acetylation fibroblast-to-myofibroblast differentiation (FMD) type-II alveolar epithelial cell (AECII) bronchiolar basal cells bronchiolization Class I-HDAC-inhibitor (pan-)HDAC-inhibitor IGF1 IGF1R lung development bleomycin-induced pulmonary fibrosis bleomycin recombinant FGF10 alveolar epithelial progenitors AT2 cells n/a thema EDItEUR::M Medicine and Nursing This reprint is a compilation of ten publications, including original-research and review articles, and the accompanying editorial within the scope of a Special Issue entitled: "State of the Art in Idiopathic Pulmonary Fibrosis" published in Cells. 2023-02-02T16:34:32Z 2023-02-02T16:34:32Z 2023 book ONIX_20230202_9783036563855_77 9783036563855 9783036563848 https://directory.doabooks.org/handle/20.500.12854/96676 eng image/jpeg Attribution 4.0 International https://mdpi.com/books/pdfview/book/6621 https://mdpi.com/books/pdfview/book/6621 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-0365-6384-8 10.3390/books978-3-0365-6384-8 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783036563855 9783036563848 220 Basel open access
spellingShingle interstitial fibrosis
lung
alveolar fibroelastosis
idiopathic pulmonary fibrosis
pirfenidone
nintedanib
discontinuation
body mass index
adverse event
antifibrotic treatment
IPF
alveolar epithelial cells
intermediate epithelial cells
transitional states
LysoTracker
flow cytometry
lung transcriptomic profile
CK5
NGFR
CD24
epidermal growth factor
epidermal growth factor receptor
ErbB-signaling
pulmonary fibrosis
lung fibrosis
tyrosine kinase inhibitor
TGF-α
TGF-β
amphiregulin
neuregulin 1
basal cells
bronchial epithelium
airway epithelium
MUC5B
single cell RNA sequencing
epithelial populations
antibody folding
immunophilin
interstitial lung disease
ER stress
tacrolimus
FK506-binding protein
peptidyl-prolyl isomerase
3D cultures
IPF modelling
drug screening
idiopathic pulmonary fibrosis (IPF)
histone deacetylase (HDAC)
histone acetylation
non-histone protein acetylation
fibroblast-to-myofibroblast differentiation (FMD)
type-II alveolar epithelial cell (AECII)
bronchiolar basal cells
bronchiolization
Class I-HDAC-inhibitor
(pan-)HDAC-inhibitor
IGF1
IGF1R
lung development
bleomycin-induced pulmonary fibrosis
bleomycin
recombinant FGF10
alveolar epithelial progenitors
AT2 cells
n/a
thema EDItEUR::M Medicine and Nursing
State of the Art in Idiopathic Pulmonary Fibrosis
title State of the Art in Idiopathic Pulmonary Fibrosis
title_full State of the Art in Idiopathic Pulmonary Fibrosis
title_fullStr State of the Art in Idiopathic Pulmonary Fibrosis
title_full_unstemmed State of the Art in Idiopathic Pulmonary Fibrosis
title_short State of the Art in Idiopathic Pulmonary Fibrosis
title_sort state of the art in idiopathic pulmonary fibrosis
topic interstitial fibrosis
lung
alveolar fibroelastosis
idiopathic pulmonary fibrosis
pirfenidone
nintedanib
discontinuation
body mass index
adverse event
antifibrotic treatment
IPF
alveolar epithelial cells
intermediate epithelial cells
transitional states
LysoTracker
flow cytometry
lung transcriptomic profile
CK5
NGFR
CD24
epidermal growth factor
epidermal growth factor receptor
ErbB-signaling
pulmonary fibrosis
lung fibrosis
tyrosine kinase inhibitor
TGF-α
TGF-β
amphiregulin
neuregulin 1
basal cells
bronchial epithelium
airway epithelium
MUC5B
single cell RNA sequencing
epithelial populations
antibody folding
immunophilin
interstitial lung disease
ER stress
tacrolimus
FK506-binding protein
peptidyl-prolyl isomerase
3D cultures
IPF modelling
drug screening
idiopathic pulmonary fibrosis (IPF)
histone deacetylase (HDAC)
histone acetylation
non-histone protein acetylation
fibroblast-to-myofibroblast differentiation (FMD)
type-II alveolar epithelial cell (AECII)
bronchiolar basal cells
bronchiolization
Class I-HDAC-inhibitor
(pan-)HDAC-inhibitor
IGF1
IGF1R
lung development
bleomycin-induced pulmonary fibrosis
bleomycin
recombinant FGF10
alveolar epithelial progenitors
AT2 cells
n/a
thema EDItEUR::M Medicine and Nursing
topic_facet interstitial fibrosis
lung
alveolar fibroelastosis
idiopathic pulmonary fibrosis
pirfenidone
nintedanib
discontinuation
body mass index
adverse event
antifibrotic treatment
IPF
alveolar epithelial cells
intermediate epithelial cells
transitional states
LysoTracker
flow cytometry
lung transcriptomic profile
CK5
NGFR
CD24
epidermal growth factor
epidermal growth factor receptor
ErbB-signaling
pulmonary fibrosis
lung fibrosis
tyrosine kinase inhibitor
TGF-α
TGF-β
amphiregulin
neuregulin 1
basal cells
bronchial epithelium
airway epithelium
MUC5B
single cell RNA sequencing
epithelial populations
antibody folding
immunophilin
interstitial lung disease
ER stress
tacrolimus
FK506-binding protein
peptidyl-prolyl isomerase
3D cultures
IPF modelling
drug screening
idiopathic pulmonary fibrosis (IPF)
histone deacetylase (HDAC)
histone acetylation
non-histone protein acetylation
fibroblast-to-myofibroblast differentiation (FMD)
type-II alveolar epithelial cell (AECII)
bronchiolar basal cells
bronchiolization
Class I-HDAC-inhibitor
(pan-)HDAC-inhibitor
IGF1
IGF1R
lung development
bleomycin-induced pulmonary fibrosis
bleomycin
recombinant FGF10
alveolar epithelial progenitors
AT2 cells
n/a
thema EDItEUR::M Medicine and Nursing
url ONIX_20230202_9783036563855_77